2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol
about
Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfallsShould dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trialsDanhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-AnalysisComing safely to a stop: a review of platelet activity after cessation of antiplatelet drugsThe circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarctionPreventing bleeding and thromboembolic complications in atrial fibrillation patients undergoing surgeryThe Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet TherapyPharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic reviewAnticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decadeRecent advances in treatment of acute coronary syndromesHigh-maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisRecent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapiesPre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study.Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies.Risk of thrombocytopenia with glycoprotein IIb/IIIa inhibitors across drugs and patient populations: a meta-analysis of 29 large placebo-controlled randomized trials.Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registryImpact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrateProvocative testing for coronary reactivity and spasm.Do diabetic patients with acute coronary syndromes have a higher threshold for ischemic pain?Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular eventsComparative accuracy of different risk scores in assessing cardiovascular risk in Indians: a study in patients with first myocardial infarction.Clinician's guide to the updated ABCs of cardiovascular disease prevention.Biopsychosocial health disparities among young women enrolled in cardiac rehabilitation.Patient-provider communication, self-reported medication adherence, and race in a postmyocardial infarction population.Atrial Fibrillation in the Young: A Neurologist's NightmareBalancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trialA simple score for predicting renal artery stenosis in patients with ischemic heart disease.A 35-Year Perspective (1975 to 2009) into the Long-Term Prognosis and Hospital Management of Patients Discharged from the Hospital After a First Acute Myocardial Infarction.Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary interventionEffect of enoxaparin on clinical events after percutaneous coronary intervention.Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy.Early Coronary Angiography and Survival After Out-of-Hospital Cardiac Arrest.Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome.Impact of treatment algorithms on the prescribing of antithrombotic therapy in patients with suspected acute coronary syndrome - a prospective audit.Use of medicines recommended for secondary prevention of acute coronary syndrome.Decade-Long Trends in the Frequency of 90-Day Rehospitalizations After Hospital Discharge for Acute Myocardial Infarction.Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failurePercutaneous coronary intervention for chronic total occlusion improved prognosis in patients with renal insufficiency at high risk of contrast-induced nephropathy.Gait and balance assessments as early indicators of frailty in patients with known peripheral artery disease.
P2860
Q26775125-D39177B9-30DB-4E4A-8ADF-9FBDD59D396BQ26782970-BEC4BD0D-9F84-47E9-B337-3E7231A326FCQ26785588-C0556777-7B7F-442A-A938-278D44C7D6A9Q26795403-464674EC-43A2-43C6-8CD4-2DDCB1EE8E05Q26798328-5A1DEBCB-FEAA-4A65-B676-30D94A393108Q26801820-A63677CE-BFE8-43AD-8E08-3346E9C1F569Q26801874-3BEB029D-1EC3-4909-88FA-C007C15AE363Q26822474-1631A5A3-F5DE-4118-BCAD-4930AAEB9B53Q26824864-2983901C-4110-4153-9583-5460AE0CBBB0Q26862897-53A98D91-D984-422A-9E6A-C1AEDD19D031Q26996325-3A1B1A20-510E-4647-85BC-CD84D7BCDABBQ27002436-A968F0D4-516D-4002-AA3E-56883C74DDBEQ31116489-BA439B06-92CB-4028-86C4-4EE014F0E89AQ31155185-F6C6F43A-C169-42CE-BB96-E5677FDB5468Q33434702-95D904DF-3503-4A45-BFE7-4847BE614CBFQ33817357-7AFC104B-4303-48E3-8D17-9535F9DB9D03Q33953368-A50F5478-09FF-48E2-952C-2666E9921E29Q34038821-06F17D0C-7560-45C3-A03D-792D7273CDE0Q34319890-AF5E5A67-358D-4282-A847-E1FCE95F08EFQ34746758-F5286B7A-6F29-4DAD-9023-FB981569C52FQ35028514-8E3C0D84-E069-440B-B310-D925F14FB635Q35070830-E71A816B-28ED-4C61-AA49-D38D34F495C8Q35126136-AF345CE6-5BA9-488B-8112-760D18A0E63AQ35130032-094347EA-6AF5-4C2A-9153-0870F5BED48DQ35438395-3FDDE15C-6C33-4C89-9B07-F310296A55FCQ35530065-7E405949-A351-4665-AC80-61537789AA00Q35584168-229C4211-82F4-426F-BA16-9D2B0B7B7684Q35644022-3B067A04-3424-4F03-B564-D552D67E94DAQ35738429-F5F45A39-94D7-4519-96B5-3E37A6271FDDQ35959359-6846C845-CC9B-428F-BAE6-38B6B6F3E4C0Q36046275-CF35E569-529B-47CE-BE30-B6E87297C43EQ36104404-F8A9DBFA-A6E1-4975-B2F5-7CF1E3D554D9Q36154461-CBBB6056-9120-4B51-913D-1535EBFEC45CQ36216424-3CEDE9E0-E615-4DE6-9109-15A0912DA423Q36243686-CD18A4BA-624F-4166-A93D-5AF186F2A4A4Q36395016-4B3BC69B-02C2-44E0-A940-80DD5D2C7331Q36578759-613CBEB4-5221-46DD-8913-1E7FEB4489DBQ36578779-CB43F3B7-06AB-45B9-BB13-59FCAC5B484FQ36602212-D4F9DA85-67ED-4695-AD09-04D63EF481A5Q36654948-81EECDF7-6E1E-4F49-80DE-EAF99C98999E
P2860
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
2012 ACCF/AHA focused update o ...... he American College of Cardiol
@en
2012 ACCF/AHA focused update o ...... levation myocardial infarction
@nl
type
label
2012 ACCF/AHA focused update o ...... he American College of Cardiol
@en
2012 ACCF/AHA focused update o ...... levation myocardial infarction
@nl
prefLabel
2012 ACCF/AHA focused update o ...... he American College of Cardiol
@en
2012 ACCF/AHA focused update o ...... levation myocardial infarction
@nl
P2093
P1476
2012 ACCF/AHA focused update o ...... he American College of Cardiol
@en
P2093
Charles R Bridges
Cynthia D Adams
Donald E Casey
Francis M Fesmire
George J Philippides
Hani Jneid
James Patrick Zidar
Jeffrey L Anderson
Nanette K Wenger
Pierre Theroux
P304
P356
10.1016/J.JACC.2012.06.004
P407
P577
2012-07-16T00:00:00Z